ARK Genomic Revolution ETF vs M&T Bank Corporation — how do they compare? ARK Genomic Revolution ETF trades at $44.26, while M&T Bank Corporation trades at $252.45 (market cap $36.42B). The key difference: M&T Bank Corporation pays a 2.38% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | MTB | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $44.55 | $254.04 |
52-Week Low | $24.02 | $178.63 |
Market Cap | — | $36.42B |
Dividend Yield | — | 2.38% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
M&T Bank (MTB) trades at $251.13, up 0.27% on the day, with a bullish technical signal and strong recent earnings beats. The stock shows consistent revenue growth, with 2025 revenue at $9.63B and net income margin of 29.59%, supported by a P/E of 13.35. Analyst consensus is a Hold with a $255.92 price target, while recent news highlights robust Q2 2026 results and dividend stability.
Outlook remains positive due to earnings momentum and loan growth, but risks include rising costs and macroeconomic pressures. The stock offers value with a reasonable valuation and dividend yield, though investor caution is warranted amid mixed analyst ratings and net cash flow challenges.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →